Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference28 articles.
1. Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap);Dearden;Ann. Oncol.,2013
2. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Non-small cell lung cancer. Version 7.2019. Available at: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed 03rd September 2019.
3. Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer;Peters;N. Engl. J. Med.,2017
4. Updated efficacy and safety data and impact of the EML4-ALK fusion variant on the efficacy of alectinib in untreated ALK-positive advanced non-small-cell lung cancer in the global phase III ALEX study;Camidge;J. Thorac. Oncol.,2019
5. Alectinib vs crizotinib in treatment-naïve ALK+ NSCLC: CNS efficacy results from the ALEX study;Gadgeel;Ann. Oncol.,2017
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献